Trial Details

ACTIVE_NOT_RECRUITING
Basic Information
Clinical ID c1227
Identifier NCT02914535
Trial Title Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: Filgotinib|DRUG: Placebo
Participant Information
Sponsor Alfasigma S.p.A.
City Dothan
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2017-02-23
Primary Completion Date 2025-09-26
Completion Date 2025-09-26